| Amyotrophic Lateral Sclerosis |
0 |
1 |
| Muscular Atrophy |
0 |
0.9 |
| Food and Drug Administration (FDA) |
0 |
0.24 |
| Cerebrospinal Fluid |
0 |
0.16 |
| Clinical Research |
0 |
0.16 |
| Europe |
0 |
0.16 |
| Genetics |
0 |
0.16 |
| Genomic Medicine |
0 |
0.16 |
| Healthcare and Medical Technology |
0 |
0.16 |
| Board Certification |
0 |
0.08 |
| Drug Development |
0 |
0.08 |
| Muscle |
0 |
0.08 |
| Neurodegenerative Diseases |
0 |
0.08 |
| Plasma |
0 |
0.08 |
| Washington |
0 |
0.08 |